NEW YORK, Jan. 22, 2018 /PRNewswire/ -- Mauna Kea Technologies (OTCQX: MKEAY; MKEAF) CEO
Sacha Loiseau was interviewed by OTC Markets Group (OTCQX: OTCM) in its prominent OTCQX® Video
Series. The series features one-on-one interviews with senior executives of OTCQX companies as they showcase their businesses and
investment profiles.
In the interview, Sacha Loiseau discusses:
- The company's unique technology platform – digital optical biopsy, which enables doctors to bring a microscope inside the
patient vs. taking a biopsy
- The benefits of digital optical biopsy including a reduction in unnecessary procedures
- The importance of the overall U.S. market, where the company's technology has received 13 different FDA clearances and is
used in 150 hospitals
To watch the complete interview, visit OTC Markets Group's YouTube page at https://www.youtube.com/watch?v=jrw8VeBczpk
About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the
diagnosis and treatment of cancer thanks to real time in vivo microscopic visualization. The Company's flagship product,
Cellvizio, has received clearance to sell a wide range of applications in more than 40 countries, including the United States, Europe, Japan,
China, Canada, Brazil and
Mexico. More than 580 systems are installed around the world and investigators have generated
more than 1,000 publications on clinical applications of endomicroscopy.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market, and the Pink®
Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we connect a diverse network of broker-dealers
that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and
empower companies to improve the quality of information available for investors.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
The information contained in this press release and in the video to which it refers is provided "as is" for educational and
informational purposes only, and should not serve as the basis for any trading or investing decisions. OTC Markets Group makes no
representations and disclaims all express, implied and statutory warranties of any kind to any viewer or third party.
Neither OTC Markets Group nor any of its affiliates makes any endorsement of any particular company, security, product or
financial strategy, and nothing contained in this video should be construed as investment advice. Investors should
undertake their own diligence and carefully evaluate companies before investing.
Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com
View original content with multimedia:http://www.prnewswire.com/news-releases/video-mauna-kea-technologies-ceo-sacha-loiseau-phd-featured-in-otcqx-video-series-300585364.html
SOURCE OTC Markets Group Inc.